BASIS OF PRESENTATION AND SUMMARY OF ACCOUNTING POLICIES - Summary of revenues disaggregated by our business operations and timing of revenue recognition (Details) - USD ($)	3 Months Ended		6 Months Ended
	Mar. 31, 2021	Mar. 31, 2020	Mar. 31, 2021	Mar. 31, 2020
Disaggregation of Revenue [Line Items]
Total	$ 2,671,542	$ 552,473	$ 4,287,683	$ 1,185,992
Research and development services (over-time)
Disaggregation of Revenue [Line Items]
Total	124,760	286,598	388,473	653,431
Equipment lease services (over-time)
Disaggregation of Revenue [Line Items]
Total	60,088	0	106,088
Clinical laboratory testing services (point-in-time)
Disaggregation of Revenue [Line Items]
Total	1,554,880	0	2,327,650
Supply chain
Disaggregation of Revenue [Line Items]
Total	67,057	12,646	99,999	31,320
Asset marking
Disaggregation of Revenue [Line Items]
Total	140,169	110,697	291,927	219,269
Large scale DNA production
Disaggregation of Revenue [Line Items]
Total	0	142,532		$ 281,972
Diagnostic kits
Disaggregation of Revenue [Line Items]
Total	$ 724,588	$ 0	$ 1,073,546